कंपनी का अवलोकन
VSee Health, Inc. operates within the healthcare sector, specifically serving the health information services industry by providing telehealth care solutions across the United States. The firm delivers iDoc Telehealth solutions designed to treat and coordinate care for acutely ill patients situated in neurointensive care, cardiac intensive care, and intensive care units addressing conditions such as stroke, spinal cord injuries, brain trauma, and other critical health issues. This entity maintains a market capitalization of $11.08M and reported annual revenue (TTM) of $14.62M, while the specific count of employees is not publicly disclosed in the available data. These financial metrics indicate that the company operates as a small-cap entity with a relatively modest revenue base, reflecting its position as a niche player focused on specialized remote care delivery rather than a broad-market healthcare conglomerate.
वित्तीय स्वास्थ्य
VSee Health, Inc. reported a revenue of $14.62M over the trailing twelve months, yet it simultaneously recorded a net income of $-14,712,850 and an EBITDA of $-6,995,337, revealing a significant divergence where operating costs and expenses substantially exceeded total earnings before interest and taxes. The company generated a free cash flow of $-967,435, which indicates a current lack of financial flexibility and a reliance on existing cash reserves or external financing to fund operations. The gross margin stands at 50.3%, suggesting that the company retains a healthy portion of revenue after direct costs, though the operating margin of -87.6% and profit margin of -100.6% demonstrate that high overhead or non-operating expenses are eroding profitability to a severe degree. Regarding liquidity and leverage, the firm holds $5.27M in cash against $3.26M in debt, resulting in a debt-to-equity ratio of 59.78, which presents a mixed picture where cash coverage is strong but the equity base is likely small given the negative returns. The current ratio is 0.52, signaling potential short-term liquidity constraints where current liabilities exceed current assets. Furthermore, the return on equity is -541.5% and the return on assets is -28.2%, metrics that reveal significant management inefficiency in generating positive returns for shareholders and utilizing asset base effectively.
मूल्यांकन आकलन
The trailing P/E ratio and forward P/E ratio are both listed as N/A due to the company's negative earnings, which precludes the use of these traditional valuation multiples for assessing the stock's intrinsic value relative to profits. The price-to-book ratio is -0.71, a negative figure that indicates the market is valuing the company below its book value, often seen in distressed or loss-making entities where tangible assets do not cover the equity claims. In terms of alternative valuation metrics, the price-to-sales ratio is 0.76 and the EV/EBITDA is -1.30, suggesting the market is pricing the stock based on revenue generation rather than earnings power, while the negative EV/EBITDA reflects the inability to cover operating expenses with current earnings. The stock has traded between a 52-week high of $2.52 and a 52-week low of $0.19, placing the current trading price within a wide historical range that highlights significant price volatility and uncertainty regarding fair value. The beta is 0.65, indicating that the stock's price volatility is lower than the broader market, suggesting it may be less sensitive to general market fluctuations compared to larger, more liquid equities.
Growth & Income
VSee Health, Inc. experienced a revenue growth of 5.1% year-over-year, whereas the earnings growth is N/A because the company is currently unprofitable, implying that top-line expansion has not yet translated into bottom-line profitability. As a non-dividend payer, the company offers a dividend yield of N/A and a payout ratio of 0.0%, meaning the firm reinvests all available cash flow back into the business or uses reserves rather than distributing income to shareholders. This absence of dividend payouts aligns with the company's strategy of preserving capital during periods of negative net income to sustain operations and potentially fund future growth initiatives. The overall growth and income profile is characterized by steady revenue expansion coupled with significant losses and a lack of shareholder distributions, presenting a high-risk, high-potential-reward scenario typical of early-stage or turnaround healthcare technology firms.